Provided by Tiger Trade Technology Pte. Ltd.

Merck

101.09
+0.40000.40%
Post-market: 101.05-0.0400-0.04%19:59 EST
Volume:44.98M
Turnover:4.55B
Market Cap:250.91B
PE:13.38
High:102.20
Open:100.60
Low:100.11
Close:100.69
52wk High:105.84
52wk Low:73.31
Shares:2.48B
Float Shares:2.48B
Volume Ratio:3.09
T/O Rate:1.81%
Dividend:3.24
Dividend Rate:3.21%
EPS(TTM):7.56
EPS(LYR):6.76
ROE:39.49%
ROA:13.76%
PB:4.84
PE(LYR):14.95

Loading ...

Merck (MRK.US), Bristol-Myers Squibb (BMY.US), and Other Pharma Giants Agree to Lower U.S. Drug Prices in Exchange for Tariff Exemptions and Policy Support

Stock News
·
Dec 20

Trump, Nine Pharmaceutical Companies Strike Deal to Cut Prices

Reuters
·
Dec 20

US FDA grants priority vouchers to Merck's cholesterol pill, cancer therapy

Reuters
·
Dec 20

BRIEF-FDA Grants Two National Priority Vouchers To Enlicitide Decanoate, Sacituzumab Tirumotecan

Reuters
·
Dec 20

Shares of Some U.S. Drugmakers Rise After Signing Drug Pricing Deal With President Trump

THOMSON REUTERS
·
Dec 20

Shares of Bristol Myers Squibb up 1.8%, Gilead Sciences up 2.9%, Amgen and Merck up Nearly 1%

THOMSON REUTERS
·
Dec 20

Why Health Care ETFs Aren't Panicking Over Big Pharma's Price Cuts

Benzinga_recent_news
·
Dec 20

BRIEF-Merck Reaches Deal With U.S. Government To Expand Access To Medicines & Lower Costs For Americans

Reuters
·
Dec 20

Trump Reportedly Strikes Drug Price Deals With 9 Pharma Companies

MT Newswires Live
·
Dec 20

Merck Announces $70 Billion Investment to Expand U.S. Manufacturing and R&D

Reuters
·
Dec 20

Merck & Co Inc - Reached an Understanding With U.S. Department of Commerce to Delay Section 232 Tariffs for Three Years

THOMSON REUTERS
·
Dec 20

Merck & Co Inc - Januvia, Janumet Available at 70% Discount

THOMSON REUTERS
·
Dec 20

Merck & Co Inc: Januvia, Janumet and Janumet Xr Will Be Available to Eligible American Patients at a Cash Price, About 70% off of Current List Price

THOMSON REUTERS
·
Dec 20

Merck & Co Inc - Commits Over $70 Bln in U.S. Investments

THOMSON REUTERS
·
Dec 20

Merck Reaches Agreement With U.S. Government to Expand Access to Medicines and Lower Costs for Americans

THOMSON REUTERS
·
Dec 20

Trump: the 3 of the 17 Pharmaceutical Companies Who Have Not Agreed Are Coming in Next Week

THOMSON REUTERS
·
Dec 20

Several Manufacturers Agree to Donate Active Pharmaceutical Ingredients to U.S. Strategic Reserve -U.S. Official

THOMSON REUTERS
·
Dec 20

Companies Agree to Sell All Future Drugs at Most Favored Nation Prices -U.S. Official

THOMSON REUTERS
·
Dec 20

14 of 17 Leading Drug Manufacturers NOW Part of Trump Administration’s Most Favored Nation Initiative -U.S. Official

THOMSON REUTERS
·
Dec 20

Companies Will Offer Many Drugs Direct-to Consumer at Lower Prices Through Trumprx Website -U.S. Official

THOMSON REUTERS
·
Dec 20